Caren van Roekel

106 Chapter 3 12. Cheng KK, Yeung RM. Symptom distress in older adults during cancer therapy: impact on performance status and quality of life. J Geriatric Oncology. 2013;4(1):71-7. Epub 2013/09/28. 13. Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, et al. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncology. 2015;1(6):778-84. Epub 2015/07/24. 14. Tohme S, Sanin GD, Patel V, Bress K, Ahmed N, Krane A, et al. Health-Related Quality of Life as a Prognostic Factor in Patients After Resection of Hepatic Malignancies. J Surg Res. 2019;245:257- 64. Epub 2019/08/20. 15. Cosimelli M, Golfieri R, Cagol PP, Carpanese L, Sciuto R, Maini CL, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer. 2010;103(3):324-31. Epub 2010/07/16. 16. Kalinowski M, Dressler M, Konig A, El-Sheik M, Rinke A, Hoffken H, et al. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study. Digestion. 2009;79(3):137-42. Epub 2009/03/25. 17. Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, et al. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol. 2013;11(10):1358-65 e1. Epub 2013/05/07. 18. Steel J, Baum A, Carr B. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttriummicrospheres (Therasphere). Psycho-oncology. 2004;13(2):73-9. Epub 2004/02/12. 19. Kolligs F T, Bilbao JI, Jakobs T, Inarrairaegui M, Nagel JM, Rodriguez M, et al. Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma. Liver International. 2015;35(6):1715-21. Epub 2014/12/03. 20. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711-20. 21. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised phase 2 trial of SIR- Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/ leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88(2):78-85. Epub 2004/10/23.